Artelo Biosciences, Inc. (ARTL) vs PMGC Holdings Inc. (ELAB)

A side-by-side comparison of Artelo Biosciences, Inc. and PMGC Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Artelo Biosciences, Inc. logo
ARTL
Artelo Biosciences, Inc.
$1M
$3.63HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
PMGC Holdings Inc. logo
ELAB
PMGC Holdings Inc.
$1M
$3.24HealthcareDelayed quote: Oct 6, 2026, 10:32 AM EDT

Total return — ARTL vs ELAB

growth of $100 · dividends reinvested · last 3y
ARTL -94.8% (-62.8%/yr)ELAB -100.0% (-99.4%/yr)ARTL compounded faster over this window
Log scale — wide-divergence pair
000001101001kStart $100202420252026$5$0
ARTL ELAB

ARTL vs ELAB: by the numbers

  • •ELAB is the larger company ($1M vs $1M market cap).
  • •Both run net losses; ARTL's is the smaller (0.00% vs -522.97% net margin).

Metrics side by side

Valuation

MetricARTLELAB
P/S ratioN/A0.57
P/B ratio0.280.09

Profitability

MetricARTLELAB
Gross margin0.00%10.31%
Operating margin0.00%-1250.11%
Net margin0.00%-522.97%
ROE-253.57%-80.57%
ROIC-219.36%N/A

Growth (annualized)

MetricARTLELAB
Total return CAGR (5Y)-64.27%N/A

Go deeper

Full ARTL analysisFull ELAB analysisInteractive comparison tool

Dig into the metrics

Artelo Biosciences ROEPMGC ROEArtelo Biosciences operating marginPMGC operating marginArtelo Biosciences revenue growthPMGC revenue growthArtelo Biosciences free cash flowPMGC free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.